A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)
Status:
Completed
Trial end date:
2014-06-30
Target enrollment:
Participant gender:
Summary
This study will evaluate the relationship between time since onset of macular oedema symptoms
and the achievement of vision gain in patients prescribed OZURDEX®. All care and diagnostic
procedures provided are at the discretion of the participating physicians according to their
clinical judgment and local standard of medical care.